PENTOXIFYLLINE
- Product NDC
- 67544-252
- 11-digit product format
- 675440252
- Labeler code
- 67544
- Product ID
- 67544-252_a6d39b9c-024a-4c09-b0c3-263456317fb4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PENTOXIFYLLINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA075191
- Marketing category
- ANDA
- Marketing start
- 1999-06-10
- Marketing end
- 0000-00-00
- Substance
- PENTOXIFYLLINE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67544-252-60 | PENTOXIFYLLINE | 90 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 90 | | 1 |
| 67544-252-92 | PENTOXIFYLLINE | 270 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 270 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| PENTOXIFYLLINE | ACTIVE INGREDIENT | SD6QCT3TSU | PENTOXIFYLLINE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| PENTOXIFYLLINE | ACTIVE MOIETY | SD6QCT3TSU | PENTOXIFYLLINE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| HYDROXYPROPYL CELLULOSE | INACTIVE INGREDIENT | RFW2ET671P | PENTOXIFYLLINE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | PENTOXIFYLLINE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | PENTOXIFYLLINE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| POLYETHYLENE GLYCOL 8000 | INACTIVE INGREDIENT | Q662QK8M3B | PENTOXIFYLLINE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | PENTOXIFYLLINE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | PENTOXIFYLLINE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67544-252 | PENTOXIFYLLINE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC, 2 package rows | 20140626_73a76a95-ada5-4707-ab89-fd60e8eda64e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 67544-252-60 | 67544025260 | 90 in 1 BOTTLE, PLASTIC | Historical |
| 67544-252-92 | 67544025292 | 270 in 1 BOTTLE, PLASTIC | Historical |